title: The HTA Core Model®-10 Years of Developing an International Framework to Share Multidimensional Value Assessment.
abstract: The HTA Core Model®as a science-based framework for assessing dimensions of value was developed as a part of the European network for Health Technology Assessment project in the period 2006 to 2008 to facilitate production and sharing of health technology assessment (HTA) information, such as evidence on efficacy and effectiveness and patient aspects, to inform decisions.
  
  
  
  It covers clinical value as well as organizational, economic, and patient aspects of technologies and has been field-tested in two consecutive joint actions in the period 2010 to 2016. A large number of HTA institutions were involved in the work.
  
  
  
  The model has undergone revisions and improvement after iterations of piloting and can be used in a local, national, or international context to produce structured HTA information that can be taken forward by users into their own frameworks to fit their specific needs when informing decisions on technology. The model has a broad scope and offers a common ground to various stakeholders through offering a standard structure and a transparent set of proposed HTA questions. It consists of three main components: 1) the HTA ontology, 2) methodological guidance, and 3) a common reporting structure. It covers domains such as effectiveness, safety, and economics, and also includes domains covering organizational, patient, social, and legal aspects. There is a full model and a focused rapid relative effectiveness assessment model, and a third joint action is to continue till 2020.
  
  
  
  The HTA Core Model is now available for everyone around the world as a framework for assessing value.
authors.affiliation: Danish Health Authority, Copenhagen, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Electronic address: fbk@dadlnet.dk.
authors.forename: Finn Børlum
authors.initials: FB
authors.lastname: Kristensen
authors.affiliation: National Institute of Health and Welfare, Helsinki, Finland.
authors.forename: Kristian
authors.initials: K
authors.lastname: Lampe
authors.affiliation: Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA), Vienna, Austria.
authors.forename: Claudia
authors.initials: C
authors.lastname: Wild
authors.affiliation: The National Agency for Regional Health Services (Agenas), Rome, Italy.
authors.forename: Marina
authors.initials: M
authors.lastname: Cerbo
authors.affiliation: Dutch National Health Care Institute (ZIN), Diemen, The Netherlands; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, The Netherlands.
authors.forename: Wim
authors.initials: W
authors.lastname: Goettsch
authors.affiliation: Danish Health Authority, Copenhagen, Denmark.
authors.forename: Lidia
authors.initials: L
authors.lastname: Becla
mesh_terms: D003657:Decision Making; D005060:Europe; D033181:Information Dissemination; D007391:International Cooperation; D008962:Models, Theoretical; D013673:Technology Assessment, Biomedical / Q000379:methods*
keywords: decision making; health care; health technology assessment; methodology